(JCPDS card no. 22-1012).25 The morphology and structure of
the product were investigated by scanning electron microscopy as
shown in Fig. 3a. It is clear from the image in Figure 3a that, the
spherically shaped ZnFe2O4 nanoparticles have diameter within
the range of ∼160-200 nm. High-resolution transmission electron
microscopy (HRTEM) at an accelerating voltage of 200 kV was
employed to know the morphology and size of prepared ZnFe2O4
nanoparticles (Fig. 3b) and the individual particles appear to be
single-crystalline, as shown by lattice imaging in Fig. 3c.
Elemental analyses of the as-synthesized ZnFe2O4 nanoparticles
were performed at EDX equipped onto SEM. Quantitative EDX
showed that Fe, Zn and O were the main elemental components
(Fig. 3d).26
was directly used in Hantzsch synthesis of 1.4-DHPs and it was
observed that, the catalyst can be reused for five times and
product obtained (Fig. S6, ESI†) in good yields. It should be
pointed out that no extra care needs to be taken in order to store
or handle the catalyst since it is not air or moisture sensitive.
In conclusion, we have developed an efficient, rapid, high-
yielding, and eco-friendly methodology for the Hantzsch
synthesis of 1,4-DHPs with ZnFe2O4-NPs as the catalyst. The
advantage of ZnFe2O4-NPs catalyst over Lewis acids lies in its
stability, moisture-insensitivity, and low cost. Further efforts will
be devoted to extend the scope of the ZnFe2O4-NPs catalyst in
other kinds of transformations. We believe that the present
improved modification is a convenient and efficient alternative to
the existing methods for the multicomponent synthesis of 1,4-
DHPs.
To examine the versatility of the ZnFe2O4-NPs, the
preparation of 1,4-DHPs was tested using a modified Hantzsch
procedure. Treatment of one equivalent of benzaldehyde 1a and
ammonium acetate 3a with 2 equiv of tert-butyl acetoacetate
(tbob) 2a in the presence of 40mg of ZnFe2O4 in water afforded
the corresponding 1,4-DHP 4a (Scheme 2,Table 1, entry 1) in
90% yield at room temperature.27 Under similar conditions,
various substituted aromatic aldehydes carrying either electron-
donating or electron-withdrawing substituents were converted
into the expected 1,4-DHPs in good to excellent yields, and the
results are summarized in Table 1. To the best of our knowledge,
this is the first report of the preparation of 1,4-DHPs catalysed by
nano crystalline ZnFe2O4 in water at room temparature.
Acknowledgements
The authors thank DeitY, Govt. of India, for a research grant
and the Department of Organic Chemistry, Indian Institute of
Science, Bangalore for providing the NMR and mass spectra.
References and notes
1. Tewari, N.; Dwevedi, N.; Tripathi, R. P. Tetrahedron Lett. 2004,
45, 9011.
2. (a) Mauzeral, D.; Westheimer, F. H. J. Am. Chem. Soc. 1955, 77,
2261; (b) Baraldi, P. G.; Chiarini, A.; Budriesi, R.; Roberti, M.;
Casolar, A.; Manfredini, S.; Simoni, D.; Zanirato, V.; Varani, K.;
Borea, P. A. Drug Des. Delivery 1989, 5, 13; (c) Baraldi, P. G.;
Budriesi, R.; Cacciari, B.; Chiarini, A.; Garuti, L.; Giovanninetti,
G.; Leoni, A.; Roberti, M. Collect. Czech. Chem. Commun. 1992,
57, 169; (d) Di Stilo, A.; Visentin, S.; Clara, C.; Gasco, A. M.;
Ermondi, G.; Gasco, A. J. Med. Chem. 1998, 41, 5393; (e)
Kawase, M.; Shah, A.; Gaveriya, H.; Motohashi, N.; Sakagami,
H.; Varga, A.; Molnar, J. Bioorg. Chem. 2002, 10, 1051; (f)
Suárez, M.; Verdecia, Y.; Illescas, B.; Martínez-Alvarez, R.;
Avarez, A.; Ochoa, E.; Seoane, C.; Kayali, N.; Martín, N.
Tetrahedron 2003, 59, 9179; (g) Shan, R.; Velazquez, C.; Knaus,
E. E. J. Med. Chem. 2004, 47, 254; (h) Sawada, Y.; Kayakiri, H.;
Abe, Y.; Mizutani, T.; Inamura, N.; Asano, M.; Hatori, C.;
Arsmori, I.; Oku, T.; Tanaka, H. J. Med. Chem. 2004, 47, 2853.
3. (a) Gordeev, M. F.; Patel, D. V.; Gordon, E. M. J. Org. Chem.
1996, 61, 924; (b) Bocker, R. H.; Guengerich, E. P. J. Med. Chem.
1986, 29, 1596. (c) Saushins, A.; Duburs, G. Heterocycles 1988,
27, 269; (d) Mager, P. P.; Coburn, R. A.; Solo, A. J.; Triggle, D.
J.; Rothe, H. Drug Des. Discovery 1992, 8, 273; (e) Boer, R.;
Gekeler, V. Drugs Future 1995, 20, 499; (f) Gullapalli, S.;
Ramarao, P. Neuropharmacology 2002, 42, 467; (g) David, J. T.
Biochem. Pharmacol. 2007, 74, 1; (h) Manhold, R.; Jablonka, B.;
Voigdt, W.; Schoenfinger, K. F.; Schravan, K. Eur. J. Med. Chem.
1992, 27, 229 ; (i) Briukhanov, V. M. Exp. Clin. Pharmacol.
1994, 57, 47; (j) Bahekar, S.; Shinde, D. Acta Pharm. (Zagreb) A
2002, 52, 281.
1
The products were characterized by H NMR, 13C NMR and
mass spectroscopy and also by comparison with authentic
samples. The advantages of the present protocols are the shorter
reaction times at room temperature, mild reaction conditions and
due to the high reactivity of the catalyst the products are obtained
in high yields. From a mechanistic point of view, the first step of
this reaction can be visualized as the ZnFe2O4-catalyzed
formation of Knoevenagel product 5. A second key intermediate
is ester enamine 6, produced by condensation of the second
equivalent of the β-ketoester with ammonia. Condensation of
these two fragments gives intermediate 7, which subsequently
cyclizes to the 1,4-dihydropyridine 4 (Scheme S1, ESI†).
Next, we decided to find the optimal amount of catalyst
(ZnFe2O4) to reach complete conversion of 1,4-DHPs at room
temperature. Initially, 10 mg of ZnFe2O4 was used as a catalyst
and it was found to give 60% yield of corresponding 1,4-DHP
(4a) (Table S1, entry 1, ESI†). On increasing the catalyst loading
from 10 to 40 mg, the yield of product was found to increase,
however on further increasing the catalyst loading no effective
increase in the yield was observed (Table S1). On the optimized
amount of catalyst, we found that 40 mg of ZnFe2O4 could
effectively catalyze the reaction for the synthesis of the desired
product. After determining the optimized conditions, we also
studied the effect of different solvent such as, EtOH, CH3N, H2O
and they were found to be efficient (Table S1). Water was chosen
as the solvent for further study because of its non-toxicity, low
cost and wide availability as compared with organic solvents.
Although Fe3O4@SiO2 and CuFe2O4 catalysed reaction produced
the product 4a in less yield within 30 min under similar reaction
conditions (Table S1, entry 4 and entry 5).
4. (a) Bossert, F.; Mayer, H.; Wehinger, E. Angew. Chem., Int. Ed.
Engl. 1981, 20, 762; (b) Gilpin, P. K.; Pachla, L. A. Anal. Chem.
1999, 71, 217; (c) Cosconati, S.; Marinelli, L.; Lavecchia, A.;
Novellino, E. J. Med. Chem. 2007, 50, 1504.
5. (a) Anniyappan, M.; Muralidharan, D.; Perumal, P. T. Synth.
Commun. 2002, 32, 659; (b) Anniyappan, M.; Muralidharan, D.;
Perumal, P. T. Synth. Commun. 2002, 32, 659; (c) Ohberg, L.;
Westman, J. Synlett 2001, 1296; (d) Lee, Y. A.; Chan, K. S. J. Ind.
Eng. Chem. 2011, 17, 401; (e) Khadilkar, B. M.; Gaikar, V. G.;
Chitnavis, A. A. Tetrahedron Lett. 1995, 36, 8083; (f) Eynde, J. J.
V.; Mayence, A. Molecules 2003, 8, 381; (g) Yadav, J. S.; Subba
Reddy, B. V.; Reddy, P. T. Synth. Commun. 2001, 31, 425.
6. (a) Liang, J.-C.; Yeh, J.-L.; Wang, C.-S.; Liou, S.-F.; Tasi, C.-H.;
Chen, I.-J. Bioorg. Med. Chem. 2002, 10, 719; (b) Miri, R.;
Niknahad, H.; Vesal, G.; Shafiee, A. IL Farmaco 2002, 57, 123;
(c) Dondoni, A.; Massi, A.; Minghini, E.; Sabbatini, S.; Bertoasi,
V. J. Org. Chem. 2003, 68, 6172; (d) Dondoni, A.; Massi, A.;
Minghini, E.; Bertoasi, V. Tetrahedron 2004, 60, 2311.
From the green chemistry point of view, efficient recovery
and reuse of the catalyst are highly desirable, thus the recovery
and reusability of ZnFe2O4-NPs were investigated. After
completion of the reaction, nanoparticles were separated by using
an external magnet. The obtained ZnFe2O4-NPs powder was
washed thoroughly with deionized water, ethanol and acetone to
remove the organic impurities. It was then dried at 70 ⁰C for 15
min and used for the next catalytic cycle. The recovered catalyst